Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 7 Breast Neoplasms 4 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Unspecified Adult Solid Tumor, Protocol Specific 2 Oligodendroglioma 2 Neoplasms 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 Glioma 2 Glioblastoma 2 Ependymoma 2 Central Nervous System Neoplasms 2 Carcinoma, Renal Cell 2 Astrocytoma 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Ewing 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Myelodysplastic Syndromes 1 Melanoma 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1

Interventions

Cyclophosphamide 10 Irinotecan 8 Melphalan 7 Vincristine 6 Temozolomide 6 Doxorubicin 6 Busulfan 6 Topotecan 5 Granulocyte Colony-Stimulating Factor 5 Gemcitabine 5 Ifosfamide 4 Filgrastim 4 Etoposide 4 Albumin-Bound Paclitaxel 4 Trabectedin 3 Sirolimus 3 Nivolumab 3 130-nm albumin-bound paclitaxel 3 pegfilgrastim 2 olaparib 2 fludarabine phosphate 2 fludarabine 2 eribulin 2 cixutumumab 2 abemaciclib 2 X-Rays 2 Radiotherapy, Intensity-Modulated 2 Peripheral Blood Stem Cell Transplantation 2 Magnetic Resonance Spectroscopy 2 Granulocyte-Macrophage Colony-Stimulating Factor 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Sarcoma, Ewing × alovudine × Clear all

NCT04067115 2025-12-17

U01CA236220

Sarcoma Alliance for Research through Collaboration

Phase 1/2 Completed

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡